sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid

C29H35N2NaO6S — CID 175061473

IUPACsodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
SMILESCc1cnc(NC(=O)CCC2CC(=O)[C@@]3(C)CCC4c5ccc(OC(=O)CCC(=O)O)cc5CCC4C23)s1.[H-].[Na+]
InChIInChI=1S/C29H34N2O6S.Na.H/c1-16-15-30-28(38-16)31-24(33)8-4-18-14-23(32)29(2)12-11-21-20-7-5-19(37-26(36)10-9-25(34)35)13-17(20)3-6-22(21)27(18)29;;/h5,7,13,15,18,21-22,27H,3-4,6,8-12,14H2,1-2H3,(H,34,35)(H,30,31,33);;/q;+1;-1/t18?,21?,22?,27?,29-;;/m1../s1
InChIKeyHHEXBEWIPINGAR-QTWXFRHRSA-N
MW562.66 g/mol
LogP2.41
Rot. Bonds8

About sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid

sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid (PubChem CID 175061473) has the molecular formula C29H35N2NaO6S and a molecular weight of 562.66 g/mol. Its IUPAC name is sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid.

Molecular Properties

Compound Namesodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
PubChem CID175061473
Molecular FormulaC29H35N2NaO6S
Molecular Weight562.66 g/mol
Exact Mass562.21
IUPAC Namesodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
SMILESCc1cnc(NC(=O)CCC2CC(=O)[C@@]3(C)CCC4c5ccc(OC(=O)CCC(=O)O)cc5CCC4C23)s1.[H-].[Na+]
InChIInChI=1S/C29H34N2O6S.Na.H/c1-16-15-30-28(38-16)31-24(33)8-4-18-14-23(32)29(2)12-11-21-20-7-5-19(37-26(36)10-9-25(34)35)13-17(20)3-6-22(21)27(18)29;;/h5,7,13,15,18,21-22,27H,3-4,6,8-12,14H2,1-2H3,(H,34,35)(H,30,31,33);;/q;+1;-1/t18?,21?,22?,27?,29-;;/m1../s1
InChIKeyHHEXBEWIPINGAR-QTWXFRHRSA-N
XLogP2.41
TPSA122.66 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500562.66
LogP ≤ 52.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phenol_ester', 'substructure': 'N/A'}

Analyze sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid?
The IUPAC name of sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid (CID 175061473) is sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid.
What is the SMILES notation for sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid?
The canonical SMILES for sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid is Cc1cnc(NC(=O)CCC2CC(=O)[C@@]3(C)CCC4c5ccc(OC(=O)CCC(=O)O)cc5CCC4C23)s1.[H-].[Na+].
What is the InChIKey of sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid?
The InChIKey is HHEXBEWIPINGAR-QTWXFRHRSA-N. The full InChI is InChI=1S/C29H34N2O6S.Na.H/c1-16-15-30-28(38-16)31-24(33)8-4-18-14-23(32)29(2)12-11-21-20-7-5-19(37-26(36)10-9-25(34)35)13-17(20)3-6-22(21)27(18)29;;/h5,7,13,15,18,21-22,27H,3-4,6,8-12,14H2,1-2H3,(H,34,35)(H,30,31,33);;/q;+1;-1/t18?,21?,22?,27?,29-;;/m1../s1.
What are the key properties of sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid?
sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid has a molecular weight of 562.66 g/mol, XLogP of 2.41, 8 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for sodium;hydride;4-[[(13S,15R)-13-methyl-15-[3-[(5-methyl-1,3-thiazol-2-yl)amino]-3-oxopropyl]-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid is sourced from PubChem (CID 175061473), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).